Forest Can't Nix Mo. Class In Antidepressant Marketing MDL

Law360, New York (January 13, 2014, 5:53 PM EST) -- A Massachusetts federal judge on Friday certified a class of Missouri parents accusing Forest Pharmaceuticals Inc. of misleading them into buying antidepressants for their children that were only approved for adults, but he refused to approve similar proposed classes of New York and Illinois consumers.

U.S. District Judge Nathaniel M. Gorton said allegations similar to those made by the drug buyers, who argued the company's purported cover-up of studies finding Celexa and Lexapro were ineffective in children denied them the ability to make an informed choice about the drugs, have been rejected by courts in New York and Illinois.

But the accusations...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!